Education, Science, Technology, Innovation and Life
Open Access
Sign In

Analysis of the Epidemiological Characteristics of Different Obesity Metabolic Phenotypes in the Adult Population of Urumqi

Download as PDF

DOI: 10.23977/socmhm.2026.070108 | Downloads: 2 | Views: 63

Author(s)

Zhang Suhong 1, Zhou Jingmin 1, Fan Jingjing 1

Affiliation(s)

1 School of Nursing, Xinjiang Medical University, 830017, Urumqi, China

Corresponding Author

Fan Jingjing

ABSTRACT

This study investigated the distribution of obesity-related metabolic phenotypes among 10,740 adults in Urumqi using multistage stratified random sampling from April 2023 to December 2024. Participants were grouped into four subtypes based on obesity and metabolic health: MHNO (52.7%), MHO (10.9%), MUNO (21.3%), and MUO (15.1%). Statistically significant differences were observed among the groups for all examined characteristics (P < 0.001). The MUO group exhibited the highest levels of key metabolic indicators, while the MHNO group had the lowest. The prevalence of MUNO and MUO increased with age, especially among those aged 60 and above. In summary, obesity-related metabolic phenotypes among Urumqi adults vary considerably, with metabolic abnormalities most pronounced among obese and older individuals.

KEYWORDS

Metabolic phenotype of obesity, Epidemiological characteristics, Adult population, Urumqi

CITE THIS PAPER

Zhang Suhong, Zhou Jingmin, Fan Jingjing. Analysis of the Epidemiological Characteristics of Different Obesity Metabolic Phenotypes in the Adult Population of Urumqi. Social Medicine and Health Management (2026). Vol. 7, No.1, 64-69. DOI: http://dx.doi.org/10.23977/socmhm.2026.070108.

REFERENCES

[1] Phelps N, Singleton R, Zhou B et al.Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. The Lancet, 2024; 403, 1027-1050
[2] Kang C ,Zewei S ,Weijun G , et al.Prevalence of obesity and associated complications in China: A cross-sectional, real-world study in 15.8 million adults.[J].Diabetes, obesity & metabolism,2023,25(11):3390-3399.
[3] World Obesity Federation. World obesity Atlas 2025[R].London: World Obesity Federation,2025. 
[4] Yang Yawen, Yu Zekai, Hu Xingang, et al. A Modern Literature Review on Traditional Chinese Medicine Interventions for Central Obesity [J]. World Journal of Traditional Chinese Medicine, 2023, 18(18): 2620–2625.
[5] Zijing W ,Wenjia P ,Mengying L , et al.Association between multimorbidity patterns and disability among older people covered by long-term care insurance in Shanghai, China.[J].BMC public health,2021,21(1):418-418.
[6] Cui Ying, Niu Zejiaxin, Wang Yang. Current Status of Research on Cardiovascular Disease Risk in Individuals with Metabolically Healthy Obesity and Metabolically Unhealthy Obesity [J]. Chinese Journal of Atherosclerosis, 2025, 33(09):737-744.
[7] Xia W ,Veeragandham P ,Cao Y , et al.Obesity causes mitochondrial fragmentation and dysfunction in white adipocytes due to RalA activation.[J].Nature metabolism,2024,6(2):273-289.
[8] Huang J ,Hong B ,Chen X , et al.Metabolically healthy obesity: unraveling phenotypic heterogeneity, biomarker signatures, and risks of progression.[J].Postgraduate medicine,2026,138(2):1-14.
[9] Wang R ,Cao L ,Zhang P , et al.Association of the skeletal muscle mass to visceral fat area ratio with metabolically healthy obesity and metabolically unhealthy non-obesity: a cross-sectional study based on NHANES 2011-2018.[J].Lipids in health and disease,2025,24(1):334.
[10] Petersen C M ,Smith I G ,Palacios H H , et al.Cardiometabolic characteristics of people with metabolically healthy and unhealthy obesity.[J].Cell metabolism,2024,36(4):745-761.e5.
[11] Chinese Nutrition Society Obesity Prevention and Control Section, et al. Expert Consensus on the Prevention and Treatment of Obesity Among Chinese Residents [J]. Chinese Journal of Preventive Medicine, 2022, 23(05): 321–339.
[12] Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).JAMA.2001;285(19):2486–2497. 
[13] Jing Hui, Teng Yuxin, Samuel Steven Chacha, et al. Epidemiological Characteristics of Metabolic Phenotype Heterogeneity in Obese Adults in Urban Areas of Shaanxi Province [J]. Chinese Journal of Public Health, 2022, 38(05): 610-613.
[14] Department of Medical Administration, National Health Commission of the People's Republic of China. Chinese Guidelines for the Diagnosis and Treatment of Obesity (2024 Edition) [J]. Journal of Peking Union Medical College, 2025, 16(01): 90–108.
[15] Tang Lijuan, Yue Fujuan, Cao Yajing, et al. A Study on the Relationship between Different Obesity Indicators and Prediabetes in Middle-Aged and Elderly Populations in Hebei Province [J]. Hebei Medicine, 2025, 47(11):1897-1901.
[16] Li Yuan, Jin Yanan, Tian Yuan, et al. Prevalence and Risk Factors of Overweight, Obesity, and Central Obesity Among Adults in Ningxia [J]. Chinese Journal of Public Health, 2019, 35(10):1360-1362.
[17] Su P ,Hsu Y ,Cheng Y , et al.Strong association between metabolically-abnormal obesity and gallstone disease in adults under 50 years[J].BMC Gastroenterology,2019,19(1):117.
[18] Zhang Jingjing, Chen Hao, Chen Xueqin, et al. Association between obesity indicators and high-density lipoprotein cholesterol mediated by type 2 diabetes and non-alcoholic fatty liver disease: A Mendelian randomization study [J]. Journal of Guangdong Medical University, 2025, 43(06): 613-621.
[19] Ye Linwei, Xu Jingjing, Hua Zhou. Analysis of the Association between Different Visceral Obesity Indices and Chronic Kidney Disease: An Analysis Based on Data from the China Health and Nutrition Survey [J]. Clinical and Educational General Practice, 2025, 23(12): 1094-1097.

Downloads: 3369
Visits: 234066

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.